Intrexon reported $142.53M in Equity Capital and Reserves for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US USD -20385000 23.8M
Amgen AMGN:US USD 3.65B 1.23B
Anika Therapeutics ANIK:US USD 284.94M 1.22M
Arrowhead Research ARWR:US USD 453.93M 1.66M
AstraZeneca AZN:LN USD 35.13B 798M
Bluebird Bio BLUE:US USD 158.86M 21.26M
Bristol Myers Squibb BMY:US USD 32.67B 71M
Gilead Sciences GILD:US USD 21.06B 821M
GlaxoSmithKline GSK:LN GBP 9.15B 7.22B
Heron Therapeutics HRTX:US USD 22.45M 44.19M
Immunogen IMGN:US USD 178.01M 71.82M
Intrexon XON:US USD 142.53M 86.88M
Karyopharm Therapeutics KPTI:US USD -140280000 23.94M
Ligand Pharmaceuticals LGND:US USD 816.3M 13.93M
Macrogenics MGNX:US USD 122.96M 19.52M
Mannkind MNKD:US USD -237677000 9.38M
Novartis NOVN:VX USD 60.82B 2.1B
Peregrine Pharmaceuticals PPHM:US USD 179M 4.47M
Rigel Pharmaceuticals RIGL:US USD 19.83M 23.51M
Sangamo Biosciences SGMO:US USD 309.15M 9.13M
Thermo Fisher Scientific TMO:US USD 43.61B 1.32B
Veracyte VCYT:US USD 1.05B 15.97M
Xencor XNCR:US USD 722.7M 19.64M
YTE INCY:US USD 4.23B 141.59M
Ziopharm Oncology ZIOP:US USD 32.11M 8.07M